BE665514A - - Google Patents
Info
- Publication number
- BE665514A BE665514A BE665514DA BE665514A BE 665514 A BE665514 A BE 665514A BE 665514D A BE665514D A BE 665514DA BE 665514 A BE665514 A BE 665514A
- Authority
- BE
- Belgium
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL646406797A NL146383B (nl) | 1964-06-16 | 1964-06-16 | Werkwijze ter bereiding van anabool werkzame 7alfa-methyl-steroiden van de oestraanreeks, alsmede werkwijze ter bereiding van een farmaceutisch preparaat en gevormd farmaceutisch preparaat. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE665514A true BE665514A (en:Method) |
Family
ID=19790312
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE665514D BE665514A (en:Method) | 1964-06-16 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US3340279A (en:Method) |
| BE (1) | BE665514A (en:Method) |
| BR (1) | BR6570429D0 (en:Method) |
| CH (1) | CH517725A (en:Method) |
| DE (1) | DE1543273C3 (en:Method) |
| DK (1) | DK114553B (en:Method) |
| FR (1) | FR1594513A (en:Method) |
| GB (1) | GB1104462A (en:Method) |
| NL (1) | NL146383B (en:Method) |
| SE (1) | SE336788B (en:Method) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2070665A1 (en:Method) * | 1969-09-03 | 1971-09-17 | Upjohn Co |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3875188A (en) * | 1968-04-10 | 1975-04-01 | Eugene E Galantay | 17-Beta-alpha-lower alkyl allene-substituted steroids |
| US3997664A (en) * | 1971-02-09 | 1976-12-14 | Sandoz, Inc. | Substituted carbinol derivatives |
| US4701450A (en) * | 1984-03-21 | 1987-10-20 | Akzo N.V. | Steroids for use as immunomodulators |
| IE63051B1 (en) * | 1989-03-18 | 1995-03-22 | Akzo Nv | Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-Hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn- 3-one |
| WO2000023460A1 (en) * | 1998-10-16 | 2000-04-27 | Akzo Nobel N.V. | HIGH PURITY COMPOSITION COMPRISING (7α,17α)- 17-HYDROXY- 7-METHYL- 19-NOR-17-PREGN- 5(10)-EN-20-YN-3-ONE |
| US20040229854A1 (en) * | 2000-11-28 | 2004-11-18 | Pieter Haan De | Immediate release dosage form for HRT |
| GB0304927D0 (en) * | 2003-03-04 | 2003-04-09 | Resolution Chemicals Ltd | Process for the production of tibolone |
| DE602004000016T2 (de) * | 2003-05-23 | 2005-11-03 | Akzo Nobel N.V. | Schnell freisetzende farmazeutische darreichungsform enthaltend polymorphes tibolon |
| EP1872775A1 (en) * | 2006-06-29 | 2008-01-02 | Polichem S.A. | Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders |
| AU2017260799B2 (en) | 2016-05-04 | 2022-11-24 | Novalon S.A. | Use of sugar-alcohols in tibolone compositions |
| US12274703B2 (en) | 2017-12-21 | 2025-04-15 | Gliapharm Sa | Compositions and methods of treatment for neurological disorders comprising a dementia |
| US12310967B2 (en) | 2017-12-21 | 2025-05-27 | Gliapharm Sa | Compositions and methods of treatment for neurological disorders comprising motor neuron diseases |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2725389A (en) * | 1953-08-31 | 1955-11-29 | Searle & Co | 13-methyl-17-ethynyl-17-hydroxy-1, 2, 3, 4, 6, 7, 8, 9, 11, 12, 13, 14, 16, 17-tetradecahydro15h-cyclopenta [a] phenanthren-3-one and its preparation |
| US3262949A (en) * | 1956-11-13 | 1966-07-26 | Syntex Corp | 7-methyl androstane compounds |
| US3086027A (en) * | 1960-01-22 | 1963-04-16 | Lilly Co Eli | 19-nor-4, 9(10)-steroids and process |
-
0
- BE BE665514D patent/BE665514A/xx unknown
-
1964
- 1964-06-16 NL NL646406797A patent/NL146383B/xx not_active IP Right Cessation
-
1965
- 1965-06-01 US US460476A patent/US3340279A/en not_active Expired - Lifetime
- 1965-06-03 GB GB23737/65A patent/GB1104462A/en not_active Expired
- 1965-06-11 CH CH814865A patent/CH517725A/de not_active IP Right Cessation
- 1965-06-14 DK DK297965AA patent/DK114553B/da unknown
- 1965-06-14 SE SE07832/65A patent/SE336788B/xx unknown
- 1965-06-15 DE DE1543273A patent/DE1543273C3/de not_active Expired
- 1965-06-15 BR BR170429/65A patent/BR6570429D0/pt unknown
- 1965-06-16 FR FR21055A patent/FR1594513A/fr not_active Expired
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2070665A1 (en:Method) * | 1969-09-03 | 1971-09-17 | Upjohn Co |
Also Published As
| Publication number | Publication date |
|---|---|
| CH517725A (de) | 1972-01-15 |
| NL6406797A (en:Method) | 1965-12-17 |
| SE336788B (en:Method) | 1971-07-19 |
| GB1104462A (en) | 1968-02-28 |
| US3340279A (en) | 1967-09-05 |
| DK114553B (da) | 1969-07-14 |
| DE1543273A1 (de) | 1969-08-07 |
| DE1543273C3 (de) | 1974-02-21 |
| BR6570429D0 (pt) | 1973-08-14 |
| DE1543273B2 (de) | 1973-07-05 |
| FR1594513A (en:Method) | 1970-06-08 |
| NL146383B (nl) | 1975-07-15 |